Novo Nordisk | NVO - Dochód Netto





Dochód Netto Zmiana Data
ANI Pharmaceuticals USD 29.49M 2.86M 2026-03
Aurora Cannabis CAD 1.82M 53.29M 2025-12
Bausch Health Companies USD -1.42B 1.31B 2026-03
Bristol-Myers Squibb USD 2.68B 1.59B 2026-03
Canopy Growth CAD -62.63M 60.99M 2025-12
Corcept Therapeutics USD -31.76M 56.05M 2026-03
Drreddys Laboratories INR 12.1B 2.08B 2025-12
Eli Lilly USD 7.4B 760M 2026-03
GlaxoSmithKline GBP 1.74B 1.1B 2026-03
Merck USD -4.24B 7.2B 2026-03
Nektar Therapeutics USD -36.08M 978K 2025-12
Novartis USD 3.16B 747M 2026-03
Novo Nordisk DKK 26.89B 388M 2025-12
Novo Nordisk DKK 4.03B 25.01B 2025-06
Pacira USD 2.92M 1.28M 2026-03
Perrigo USD -398.6M 1.02B 2026-03
Phibro Animal Health USD 27.46M 932K 2025-12
Prestige Brands USD 46.7M 22.44M 2025-12
Sanofi EUR 1.61B 2.42B 2026-03
Supernus Pharmaceuticals USD -2.29M 1.81M 2026-03
Zoetis USD 601M 2M 2026-03